Wells Fargo & Company Pulmonx Corp Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Pulmonx Corp stock. As of the latest transaction made, Wells Fargo & Company holds 18,418 shares of LUNG stock, worth $128,741. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,418

Previous 12,385 48.71%

Holding current value

$128,741

Previous $102,000 22.55%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$5.93 - $7.71 $35,775 - $46,514	6,033 Added 48.71%	18,418 $125,000
Q3 2024 Nov 13, 2024	SELL	$5.59 - $8.58 $100 - $154	-18 Reduced 0.15%	12,385 $102,000
Q2 2024 Aug 13, 2024	BUY	$5.77 - $9.82 $5,394 - $9,181	935 Added 8.15%	12,403 $78,000
Q1 2024 May 10, 2024	BUY	$8.71 - $14.65 $9,868 - $16,598	1,133 Added 10.96%	11,468 $106,000
Q4 2023 Feb 09, 2024	BUY	$7.89 - $13.14 $23,204 - $38,644	2,941 Added 39.78%	10,335 $131,000
Q3 2023 Nov 13, 2023	SELL	$9.88 - $14.0 $138,102 - $195,692	-13,978 Reduced 65.4%	7,394 $76,000
Q2 2023 Aug 15, 2023	BUY	$10.78 - $13.65 $93,635 - $118,563	8,686 Added 68.47%	21,372 $280,000
Q1 2023 May 12, 2023	BUY	$7.49 - $12.54 $92,733 - $155,257	12,381 Added 4059.34%	12,686 $141,000
Q4 2022 Feb 13, 2023	SELL	$4.92 - $17.35 $4,108 - $14,487	-835 Reduced 73.25%	305 $2,000
Q3 2022 Nov 14, 2022	SELL	$15.35 - $23.99 $14,091 - $22,022	-918 Reduced 44.61%	1,140 $19,000
Q2 2022 Aug 12, 2022	SELL	$14.0 - $27.95 $1.29 Million - $2.58 Million	-92,132 Reduced 97.82%	2,058 $30,000
Q1 2022 May 16, 2022	SELL	$21.13 - $35.65 $75,074 - $126,664	-3,553 Reduced 3.64%	94,190 $2.34 Million
Q4 2021 Feb 14, 2022	SELL	$29.72 - $45.1 $6.64 Million - $10.1 Million	-223,455 Reduced 69.57%	97,743 $3.14 Million
Q3 2021 Nov 15, 2021	BUY	$35.98 - $44.48 $1.37 Million - $1.69 Million	37,998 Added 13.42%	321,198 $11.6 Million
Q2 2021 Aug 16, 2021	BUY	$37.61 - $48.0 $971,992 - $1.24 Million	25,844 Added 10.04%	283,200 $12.5 Million
Q1 2021 May 13, 2021	SELL	$44.0 - $67.54 $549,604 - $843,642	-12,491 Reduced 4.63%	257,356 $11.8 Million
Q4 2020 Feb 09, 2021	BUY	$39.31 - $69.02 $10.6 Million - $18.6 Million	269,847 New	269,847 $18.6 Million

Others Institutions Holding LUNG

# of Institutions

130

Shares Held

31.4M

Call Options Held

500

Put Options Held

213K

View Full List

About Pulmonx Corp

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $261M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

More about LUNG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Pulmonx Corp Transaction History